FDA Approved: KUVAN — Supplemental Application (BioMarin Pharmaceutical Inc.)

View source ↗

Summary

The FDA approved BioMarin's supplemental application for Kuvan (sapropterin dihydrochloride), confirming FDA authorization of changes included in the supplement…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• KUVAN (Sapropterin dihydrochloride)

Snippet

SUPPL AP for KUVAN (SAPROPTERIN DIHYDROCHLORIDE)